has been cited by the following article(s):
[1]
|
Sonodynamic Therapy for the Treatment of Intracranial Gliomas
Journal of Clinical Medicine,
2021
DOI:10.3390/jcm10051101
|
|
|
[2]
|
Intracranial Sonodynamic Therapy With 5-Aminolevulinic Acid and Sodium Fluorescein: Safety Study in a Porcine Model
Frontiers in Oncology,
2021
DOI:10.3389/fonc.2021.679989
|
|
|
[3]
|
Current Landscape of Sonodynamic Therapy for Treating Cancer
Cancers,
2021
DOI:10.3390/cancers13246184
|
|
|
[4]
|
Fluorescein-mediated sonodynamic therapy in a rat glioma model
Journal of Neuro-Oncology,
2020
DOI:10.1007/s11060-020-03536-2
|
|
|
[5]
|
Sonodynamic Therapy for Malignant Glioma Using 220-kHz Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound and 5-Aminolevulinic acid
Ultrasound in Medicine & Biology,
2019
DOI:10.1016/j.ultrasmedbio.2018.10.016
|
|
|
[6]
|
Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma
Tumor Biology,
2016
DOI:10.1007/s13277-016-4931-3
|
|
|
[7]
|
Identification of Pathological and Normal Parathyroid Tissue by Fluorescent Labeling with 5-aminolevulinic Acid during Endocrine Neck Surgery
Journal of Nippon Medical School,
2014
DOI:10.1272/jnms.81.84
|
|
|